Michael h tardugno
Webb20 juni 2024 · Michael has made over 33 trades of the Imunon Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently he bought 4,000 units of CLSN stock worth $14,120 on 12 April 2024. Michael Tardugno Net Worth (2024) wallmine Webb23 juni 2024 · Michael H. Tardugno, Celsion’s chairman, president and chief executive officer, said, “Despite the bitter disappointment and surprise with our Phase III OPTIMA study of ThermoDox®in primary liver cancer, many investigators are undaunted by various anomalies related to that data and see value in the drug’s continued study.
Michael h tardugno
Did you know?
Webb3 mars 2024 · LAWRENCEVILLE, N.J., March 03, 2024 -- Celsion Corporation , a leading oncology drug development company, announces that Michael H. Tardugno, the … WebbMr. Michael H. Tardugno. Mr. Tardugno was appointed President and Chief Executive Officer of the Company on January 3, 2007 and was elected to the Board of Directors on January 22, 2007. In October of 2014, Mr. Tardugno was appointed by the Board of Directors as the Chairman as successor to Max E. Link, Ph.D., who passed away in …
WebbMichael H. Tardugno Joins Company from Mylan Technologies, Inc . Columbia, MD – December 21, 2006: CELSION CORPORATION (AMEX: CLN) today announced the appointment of Michael H. Tardugno, as President and Chief Executive Officer, effective January 3, 2007. WebbThis 2nd Amendment, is effective on JANUARY 7, 2011, to amend the DEVELOPMENT, PRODUCT SUPPLY AND COMMERCIALIZATION AGREEMENT (the “Agreement”), which was executed on DECEMBER 5, 2008, and amended on JULY 1, 2010 by and between Celsion Corporation, a corporation organized and existing under the laws of …
WebbThe Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. … Webb2 dec. 2024 · Michael H. Tardugno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have …
Webb19 juli 2024 · Current President and CEO Michael H. Tardugno will continue to serve as Executive Chairman of Celsion’s Board of Directors. Dr. Le Goff brings decades of …
Webb11 feb. 2024 · Michael H. Tardugno Chairman, President and Chief Executive Officer February 11, 2024. About Celsion Corporation. Celsion is a fully integrated, clinical … florida state university race ratioWebbFound 22 colleagues at Celsion Corporation. There are 6 other people named Michael H. Tardugno on AllPeople. Find more info on AllPeople about Michael H. Tardugno and … florida state university poolWebb18 juli 2024 · Current President and CEO Michael H. Tardugno will continue to serve as Executive Chairman of Celsion’s Board of Directors. Dr. Le Goff brings decades of … great white shark photos underwaterWebb12 mars 2015 · Michael H. Tardugno - Chairman, President and Chief Executive Officer Nicholas Borys - Senior Vice President and Chief Medical Officer Analysts Keith A. … florida state university randy mossflorida state university roboticsWebb22 feb. 2024 · Michael H. Tardugno. The Data Safety Monitoring Board (DSMB) for the ongoing phase 1/2 OVATION 2 trial (NCT033393884) has unanimously recommended that patients continue to receive treatment with ... great white shark physical appearanceWebb13 feb. 2014 · DNA methyltransferases (DNMTs) are important enzymes involved in epigenetic control of gene expression and represent valuable targets in cancer chemotherapy. A number of nucleoside DNMT inhibitors (DNMTi) have been studied in cancer, including in cancer stem cells, and two of them (azacytidine and d … great white shark physical adaptations